MedTrace Logo

Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation

NCT01275534 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 375

Last updated 2013-01-17

No results posted yet for this study

Summary

In the study PROVIVO, a patient reported outcome instrument consisting of items from the PRO-CTCAE item bank measuring symptom experience of long-term survivors after allogeneic hematopoietic stem cell transplantation (SCT) will be developed. The instrument development is based on cognitive patient interviews, a survey of hematology experts and a literature review. In a subsequent cross-sectional study phase, the instrument will be validated in a sample of 300 allogeneic stem cell recipients and by the use of additional self report instruments it will be possible to explore how subjective symptom experience, problems in self-management and presence of late effects are connected.

Conditions

  • Hematologic Neoplasms

Sponsors & Collaborators

  • University of Basel

    collaborator OTHER

  • University Hospital, Zürich

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Sabina De Geest, PhD · University of Basel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01275534 on ClinicalTrials.gov